178 related articles for article (PubMed ID: 16026775)
1. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer.
Yagihashi A; Ohmura T; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Hirata K; Watanabe N
Clin Chim Acta; 2005 Dec; 362(1-2):125-30. PubMed ID: 16026775
[TBL] [Abstract][Full Text] [Related]
2. Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Shijubo Y; Abe S; Hirohashi Y; Torigoe T; Sato N; Watanabe N
Lung Cancer; 2005 May; 48(2):217-21. PubMed ID: 15829321
[TBL] [Abstract][Full Text] [Related]
3. [Anti-survivin and anti-livin antibodies].
Yagihashi A
Nihon Rinsho; 2010 Jun; 68 Suppl 6():708-10. PubMed ID: 20942170
[No Abstract] [Full Text] [Related]
4. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses to survivin and their clinical significance in patients with head and neck cancer.
Eto M; Kodama S; Uemura N; Suzuki M
Head Neck; 2007 Dec; 29(12):1128-35. PubMed ID: 17636541
[TBL] [Abstract][Full Text] [Related]
6. Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients.
Kitamura H; Honma I; Torigoe T; Hariu H; Asanuma H; Hirohashi Y; Sato E; Sato N; Tsukamoto T
Urology; 2007 Jul; 70(1):38-42. PubMed ID: 17656204
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic tests: Anti-Survivin and anti-Livin antibodies].
Yagihashi A
Nihon Rinsho; 2005 Jul; 63 Suppl 7():637-9. PubMed ID: 16111355
[No Abstract] [Full Text] [Related]
9. Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy.
Kitamura H; Torigoe T; Honma I; Asanuma H; Nakazawa E; Shimozawa K; Hirohashi Y; Sato E; Sato N; Tsukamoto T
Urology; 2006 May; 67(5):955-9. PubMed ID: 16635519
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to survivin in the sera of patients with infiltrating ductal carcinoma of the breast.
Al-Joudi FS; Iskandar ZA
Med J Malaysia; 2006 Aug; 61(3):302-6. PubMed ID: 17240580
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.
Rohayem J; Diestelkoetter P; Weigle B; Oehmichen A; Schmitz M; Mehlhorn J; Conrad K; Rieber EP
Cancer Res; 2000 Apr; 60(7):1815-7. PubMed ID: 10766164
[TBL] [Abstract][Full Text] [Related]
13. A new subtype-specific monoclonal antibody for IAP-survivin identifies high-risk patients with diffuse large B-cell lymphoma and improves the prognostic value of bcl-2.
Mainou-Fowler T; Overman LM; Dignum H; Wood K; Crosier S; Angus B; Proctor SJ; Anderson JJ
Int J Oncol; 2008 Jan; 32(1):59-68. PubMed ID: 18097543
[TBL] [Abstract][Full Text] [Related]
14. Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.
Kleinberg L; Flørenes VA; Nesland JM; Davidson B
Am J Clin Pathol; 2007 Sep; 128(3):389-97. PubMed ID: 17709312
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection.
Megliorino R; Shi FD; Peng XX; Wang X; Chan EK; Tan EM; Zhang JY
Cancer Detect Prev; 2005; 29(3):241-8. PubMed ID: 15896923
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to the inhibitor of apoptosis protein survivin in patients with brain tumors.
Söling A; Plugge EM; Schmitz M; Weigle B; Jacob R; Illert J; Holzhausen HJ; Rainov NG
Int J Oncol; 2007 Jan; 30(1):123-8. PubMed ID: 17143520
[TBL] [Abstract][Full Text] [Related]
17. Correlation between anti-survivin antibody and survivin mRNA expression in head and neck cancer patients.
Uemura N; Kodama S; Nomi N; Okamoto T; Suzuki M
Acta Otolaryngol; 2010 Aug; 130(8):959-65. PubMed ID: 20100132
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitor of apoptosis in lung cancer Livin perioperative clinical research].
Wang LN; Mou J; Zhang YB; Dong P; Diao X; Wang SY; Chen H; Liu YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Sep; 26(9):889-90. PubMed ID: 20815986
[TBL] [Abstract][Full Text] [Related]
19. [RNAi-mediated gene silencing of livin synergistic with epirubicin enhance apoptosis of human breast cancer cells].
Liang CY; Ma P; Liu XL
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1703-6. PubMed ID: 19024543
[TBL] [Abstract][Full Text] [Related]
20. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]